BBNX Sale Disclosure
Hopman Mark · SEC Form 4 · Filed Oct 28, 2026
Sale
Calculated transaction value
$16.42K
Hopman Mark Chief Commercial Officer
BBNX
Beta Bionics
BBNX
Transaction date
Oct 26, 2026
Public filing date
Oct 28, 2026
Filing lag
Filed 2 days later
BBNX daily price context
Close on/before transaction
$20.51
Oct 26, 2026
First close after public filing
$17.58
Oct 29, 2026
Return after filing · so far
-10.69%
Through Nov 6, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 821 shares @ $20
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0002048497-26-000023
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$16.42K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Beta Bionics, Inc. BBNX Current | Sale | Oct 26, 2026 | $16.42K |